Article Versions Notes

Ferlenghi F, Giorgio C, Incerti M, Guidetti L, Chiodelli P, Rusnati M, Tognolini M, Vacondio F, Mor M, Lodola A. Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice. Pharmaceuticals. 2022; 15(1):41. https://doi.org/10.3390/ph15010041

Ferlenghi, Francesca, Carmine Giorgio, Matteo Incerti, Lorenzo Guidetti, Paola Chiodelli, Marco Rusnati, Massimiliano Tognolini, Federica Vacondio, Marco Mor, and Alessio Lodola. 2022. "Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice" Pharmaceuticals 15, no. 1: 41. https://doi.org/10.3390/ph15010041

Ferlenghi, F., Giorgio, C., Incerti, M., Guidetti, L., Chiodelli, P., Rusnati, M., Tognolini, M., Vacondio, F., Mor, M., & Lodola, A. (2022). Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice. Pharmaceuticals, 15(1), 41. https://doi.org/10.3390/ph15010041